0.00Open0.00Pre Close0 Volume0 Open Interest64.00Strike Price0.00Turnover878.70%IV-17.44%PremiumDec 13, 2024Expiry Date13.52Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9677Delta0.0087Gamma5.70Leverage Ratio-5.2224Theta0.0001Rho5.52Eff Leverage0.0007Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet